| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/12/2010 | CN101007064B Isolation and purification method of lotus leaf extract by macroporous resin and its application thereof |
| 05/12/2010 | CN101007058B Medicinal composition for treating bronchial asthma, chronic bronchitis and emphysema |
| 05/12/2010 | CN101002847B Medicine for treating mazoplasia, and its preparing method |
| 05/12/2010 | CN100998673B Compound cream containing fluconazole and Radix scutellariae and its preparing method |
| 05/12/2010 | CN100998638B Traditional Chinese medicine for nourishing liver and kidney, nourishing blood and invigorating the circulation of blood |
| 05/12/2010 | CN100998617B Quality control method for Xindakang preparation |
| 05/11/2010 | US7714183 the honey composition effects a change in the physical characteristics of the dressing; especially for chronic wound care |
| 05/11/2010 | US7714107 Freeze-dried fibrin matrices and methods for preparation thereof |
| 05/11/2010 | US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 05/11/2010 | US7714011 Compositions to reduce congestion and methods for application thereof to the nasal membrane |
| 05/11/2010 | US7714003 Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides |
| 05/11/2010 | US7713963 Acylated indanyl amines and their use as pharmaceuticals |
| 05/11/2010 | US7713959 Affecting weight loss, increasing energy expenditure, increasing satiety; zonisamide |
| 05/11/2010 | US7713947 Cladribine regimen for treating multiple sclerosis |
| 05/11/2010 | US7713942 Drug delivery able crossing cellular membranes; transdermal, electrostatic interaction and a hydrophobic interaction |
| 05/11/2010 | US7713939 1-Substituted-[1H-indene-6,1'-cyclopropane]-4-one derivatives: solid tumors and multi-drug resistant tumors; -cell leukemia, B-cell lymphoma, myeloma, T-cell leukemia, T-cell lymphoma, small leukemia, and small cell lymphoma |
| 05/11/2010 | US7713930 Acidic insulin preparations having improved stability |
| 05/11/2010 | US7713552 Radiopaque implantable collagenous biomaterial device |
| 05/11/2010 | US7713551 Dosage form containing a drug having average particle size of less than about 2000 nm prior to inclusion in the formulation, a surfactant and a gel forming agent selected from natural gelatin, a semi-syntheic gelatin, and a synthetic gelatin |
| 05/11/2010 | US7713550 Controlled release sodium valproate formulation |
| 05/11/2010 | US7713549 tablet is in form of coated donut-shaped tablet or multilayer donut-shaped tablet so that immediate release or time-delayed release can be achieved; may provide zero order or first order extended release kinetics depending on excipients and types of pharmaceutically active ingredients in formulation |
| 05/11/2010 | US7713548 Amorphous solid dispersions |
| 05/11/2010 | US7713547 Method of administering a partial dose of a segmented pharmaceutical tablet |
| 05/11/2010 | US7713546 unitary soft gel capsule for oral administration is prepared by heating rice bran oil under reduced pressure, adding a filler and then corosolic acid, cooling, encapsulating into a soft gel capsule; increased absorption of corosolic acid in human body |
| 05/11/2010 | US7713545 N-glycoside type glycolipids and hollow fiber type organic nanotubes made of the same |
| 05/11/2010 | US7713544 Biological component comprising artificial membrane |
| 05/11/2010 | US7713543 Elastin stabilization of connective tissue |
| 05/11/2010 | US7713529 Methods for treating and preventing infectious disease |
| 05/11/2010 | US7713523 Solubilized CoQ-10 and carnitine |
| 05/11/2010 | US7713518 Capsule for a powder medicament |
| 05/11/2010 | US7713517 Compositions and methods for enhancing contrast in imaging |
| 05/11/2010 | US7713440 Ionization; dispersion in polar solvent |
| 05/11/2010 | US7713350 Inorganic colors and related nanotechnology |
| 05/11/2010 | US7713262 Disposable infusion device with linear peristaltic pump |
| 05/11/2010 | US7713255 Sinus delivery of sustained release therapeutics |
| 05/11/2010 | US7713241 Rapid infusion system |
| 05/11/2010 | CA2488868C Controlled release formulation of lamotrigine |
| 05/11/2010 | CA2470342C Ribavirin granulate for producing coated tablets |
| 05/11/2010 | CA2464485C Microneedle transdermal transport device |
| 05/11/2010 | CA2461958C Combination dosage form containing a cholesterol-lowering agent, a renin-angiotensin inhibitor, and aspirin |
| 05/11/2010 | CA2455134C Adjuvants for use in vaccines |
| 05/11/2010 | CA2442448C Condom with an erectogenic composition |
| 05/11/2010 | CA2428994C Improved ophthalmic and contact lens solutions containing forms of vitamin b |
| 05/11/2010 | CA2417709C Compositions and dosage forms for application in the oral cavity in the treatment of mykoses |
| 05/11/2010 | CA2403343C Process for the preparation of accelerated release formulations using compressed fluids |
| 05/11/2010 | CA2392570C 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 05/11/2010 | CA2391707C Multi-component pharmaceutical dosage form |
| 05/11/2010 | CA2362550C Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 05/11/2010 | CA2355651C Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide |
| 05/11/2010 | CA2165297C Myeloid cell leukemia associated gene mcl-1 |
| 05/06/2010 | WO2010051312A1 Osmotic tablet with a compressed outer coating |
| 05/06/2010 | WO2010051038A1 Compositions of activated botulinum holotoxin type b (150 kd) |
| 05/06/2010 | WO2010050980A1 Topical formulations comprising hydroxyapatite particles for stimulation and maintenance of collagen fibers |
| 05/06/2010 | WO2010050955A1 Broad spectrum microbicidal and spermicidal compositions and methods |
| 05/06/2010 | WO2010050918A1 Branched chain detergents for membrane protein structural biology |
| 05/06/2010 | WO2010050897A1 Mesoporous material excipients for poorly aqueous soluble ingredients |
| 05/06/2010 | WO2010050889A1 Topical composition comprising a combination of at least two penetration enhancing agents |
| 05/06/2010 | WO2010050794A1 Cardioprotective effects of nutraceuticals isolated from nigella sativa seeds |
| 05/06/2010 | WO2010050787A2 Encapsulated functional fine particle composition capable of spraying and preparation method thereof |
| 05/06/2010 | WO2010050578A1 Mucosal vaccine using cationic nanogel |
| 05/06/2010 | WO2010050423A1 Ondansetron-containing external drug composition |
| 05/06/2010 | WO2010050168A1 Solid solution of valine, isoleucine and leucine, and method for producing same |
| 05/06/2010 | WO2010049954A1 Fatty acids for use as a medicament |
| 05/06/2010 | WO2010049900A1 Statin nanoparticles |
| 05/06/2010 | WO2010049899A1 Nanoparticles of beta-lactam derivatives |
| 05/06/2010 | WO2010049637A1 Aqueous saline solutions for the destruction of fatty tissue |
| 05/06/2010 | WO2010049562A1 Nanoparticulate systems prepared from anionic polymers |
| 05/06/2010 | WO2010049499A1 Formulation for treatment of vaginal dryness |
| 05/06/2010 | WO2010049485A2 Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate |
| 05/06/2010 | WO2010049433A2 Water insoluble polymer: starch-based film coatings for colon targeting |
| 05/06/2010 | WO2010049432A1 Water insoluble polymer: indigestible water-soluble polysaccharide film coatings for colon targeting |
| 05/06/2010 | WO2010049423A1 Effects of nitric oxide inhalation on long-term myocardial reperfusion injury |
| 05/06/2010 | WO2010049062A1 Controllable therapeutic system |
| 05/06/2010 | WO2010048981A1 Sprayable pharmaceutical compositions comprising sucralfate gel for treating skin or mucosa lesions |
| 05/06/2010 | WO2010048788A1 A ophthalmic flurbiprofen ester nano-emulsion in-situ gel formulation and the preparation method thereof |
| 05/06/2010 | WO2010029344A3 Hyaluronic acid cryogel - compositions, uses, processes for manufacturing |
| 05/06/2010 | WO2010002965A3 Pneumonia treatment |
| 05/06/2010 | WO2009151520A3 Biocompatible and biodegradable elastomeric polymers |
| 05/06/2010 | WO2009133573A3 A homeopathic formulation |
| 05/06/2010 | WO2009131939A9 Lipid-containing compositions and methods of use thereof |
| 05/06/2010 | WO2009118359A3 Capsule for the prevention of cardiovascular diseases |
| 05/06/2010 | WO2009100367A3 Compositions comprising topical dpd inhibitors and methods of using same in the treatment of hand-foot syndrome |
| 05/06/2010 | WO2009090027A3 Carrier pellets, method for the production thereof and use thereof |
| 05/06/2010 | WO2009064374A3 Oral formulations of bis(thiohydrazide amides) |
| 05/06/2010 | US20100115638 Method for inhibiting the expression of endogenous erythropoietin (epo) |
| 05/06/2010 | US20100114129 Tissue joining devices capable of delivery of bioactive agents and methods of use thereof |
| 05/06/2010 | US20100114075 Device and method for directional delivery of a drug depot |
| 05/06/2010 | US20100114074 Sustained delivery of an active agent using an implantable system |
| 05/06/2010 | US20100114066 Implantable devices and methods for delivering drugs and other substances to treat sinusitis and other disorders |
| 05/06/2010 | US20100114014 Pharmaceutical compositions stabilised in glassy particles |
| 05/06/2010 | US20100113861 Metallic nanoparticles with coated shells and applications of same |
| 05/06/2010 | US20100113619 High-amylose sodium carboxymethyl starch sustained release excipient and process for preparing the same |
| 05/06/2010 | US20100113618 Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same |
| 05/06/2010 | US20100113607 Pharmaceutical Compositions |
| 05/06/2010 | US20100113501 Ophthalmic Composition Comprising Ascomycin |
| 05/06/2010 | US20100113426 Intranasal Benzodiazepine Compositions |
| 05/06/2010 | US20100112188 Novel stable beadlets of lipophilic nutrients |
| 05/06/2010 | US20100112162 25-Hydroxy vitamin D3 compositions |
| 05/06/2010 | US20100112079 Thyroid Hormone Analogs and Methods of Use |
| 05/06/2010 | US20100112078 Polymer particles based vaccine |